Characterization of bacteriophage derived anti-staphylococcal protein (P128) from production to purification using Agilent HPLC-Chip Q-TOF LC/MS system

Applications | 2011 | Agilent TechnologiesInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies

Summary

Importance of the Topic


The emergence of methicillin-resistant Staphylococcus aureus (MRSA) has created an urgent need for novel antibacterial agents. P128, a bacteriophage-derived peptidoglycan hydrolase, shows potent anti-staphylococcal activity and is under development for both topical and systemic applications. Reliable analytical methods are essential during early development to monitor protein purity, detect process-related impurities, and ensure structural integrity prior to clinical evaluation.

Objectives and Overview of the Study


This study demonstrates an integrated approach for monitoring in-process samples and purified P128 using a microfluidic HPLC-Chip coupled to an Accurate-Mass Q-TOF LC/MS system. Key aims were to assess the removal of additives and host-cell contaminants during purification, to accurately measure the intact molecular weight of P128, and to highlight the utility of advanced data processing for rapid impurity profiling.

Methodology and Instrumentation


Sample preparation and chromatographic separation were performed on an Agilent 1200 Series HPLC-Chip interface with a 40 nL enrichment column and a 75 mm × 43 mm ZORBAX 300SB-C8 analytical column. Two pumps delivered 3 µL/min (capillary) and 600 nL/min (nanoflow) gradients of 0.1% formic acid (A) and 90% acetonitrile/0.1% formic acid (B). An Agilent 6520 Accurate-Mass Q-TOF captured positive-mode spectra (300–3200 m/z) with internal mass calibration. Data processing utilized Agilent MassHunter Qualitative Analysis, the Large Molecule Feature Extractor (LMFE) algorithm, and BioConfirm software. LMFE deconvolutes multiply charged ion patterns into co-elution groups, enabling automated detection of intact proteins and modifications.

Main Results and Discussion


• The LMFE algorithm detected 256 components in crude lysate in 10 minutes versus 112 proteins in 45 minutes by traditional maximum entropy deconvolution, demonstrating a two-fold increase in information and a three-fold gain in speed.
• A prominent peak at 27–30 minutes was identified as Triton X-100, confirming retention of this additive in early purification steps and highlighting the sensitivity of LC/MS over SDS-PAGE.
• Progressive purification reduced the number of detected compounds from 256 (crude lysate) to 6 in the final P128 preparation, verifying removal of host-cell proteins and small-molecule contaminants.
• The intact mass of purified P128 was measured at 26489.2 Da, within 4 ppm of the theoretical value (26489.13 Da). Minor peaks indicated low-level oxidation and hydroxylation variants.

Benefits and Practical Applications


• High sensitivity and specificity for low-abundance impurities such as detergents or polyethyleneimine, often undetectable by gel-based methods.
• Reduced sample and solvent consumption due to nanoflow chromatography, with improved run-to-run reproducibility essential for quality control.
• Rapid and automated data analysis using LMFE accelerates decision-making in process development.
• Plug-and-play HPLC-Chip formats (C8, C18, PGC, phospho-chips) allow versatile analyses on a single platform.

Future Trends and Possibilities


• Integration of real-time LC/MS monitoring with manufacturing control systems for continuous process verification.
• Expansion of microfluidic chip chemistries to enhance separation of post-translational modifications and variants.
• Adoption of top-down proteomics workflows leveraging high-resolution Q-TOF instruments for deeper structural characterization.
• Development of AI-driven data analysis pipelines to further reduce interpretation time and improve impurity prediction.

Conclusion


The combination of Agilent HPLC-Chip nanoLC and Accurate-Mass Q-TOF MS, paired with advanced algorithms such as LMFE, provides a robust, sensitive, and rapid platform for characterizing recombinant proteins and monitoring impurities throughout the production process. This approach supports early identification of critical quality attributes, facilitating smoother progression from lab-scale development to clinical manufacturing.

Reference


  1. Faster, More Accurate Characterization of Proteins and Peptides with Agilent MassHunter BioConfirm Software (5990-5096EN).
  2. Gudihal R. et al. Characterization of Bacteriophage Derived Anti-staphylococcal Protein (P128) from Production to Purification Using Microfluidic Based LC System Coupled to an Advanced QTOF-MS. ASMS Poster, 2010.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Determination of Drug-to-Antibody Ratio for Antibody-Drug Conjugates Purified from Serum
Determination of Drug-to-Antibody Ratio for Antibody-Drug Conjugates Purified from Serum Using Automated Affinity Purification, LC/MS analysis, and Novel DAR Calculation Software Application Note Authors Introduction Jing Chen, Michael Bovee, and Antibody-drug conjugates (ADCs) are an emerging class of biotherapeutics designed…
Key words
adc, adcaffinity, affinityserum, serumdar, darpurified, purifiedassaymap, assaymapadcs, adcsdeconvoluted, deconvolutedcounts, countspurification, purificationbravo, bravocartridges, cartridgescommercially, commerciallyantigen, antigencopurified
BioPharma Applications Compendium - AGILENT APPLICATIONS FOR BIOPHARMACEUTICAL DISCOVERY, DEVELOPMENT AND QA/QC
BioPharma Applications Compendium AGILENT APPLICATIONS FOR BIOPHARMACEUTICAL DISCOVERY, DEVELOPMENT AND QA/QC s s s s P L A Y R P L A Y R Q S M A Y R Q S M N N F S M N…
Key words
monoclonal, monoclonalagilent, agilentantibody, antibodyantibodies, antibodiesanalysis, analysisprotein, proteinusing, usingglycan, glycanelectrophoresis, electrophoresispeptide, peptidemapping, mappingsolutions, solutionsbio, biozorbax, zorbaxmab
Identification of Oxidation Sites on a Monoclonal Antibody Using an Agilent 1260 Infinity HPLC-Chip/MS System Coupled to an Accurate-Mass 6520 Q-TOF LC/MS
Identification of Oxidation Sites on a Monoclonal Antibody Using an Agilent 1260 Infinity HPLC-Chip/MS System Coupled to an Accurate-Mass 6520 Q-TOF LC/MS Application Note Authors Abstract Ravindra Gudihal Agilent Technologies India Pvt. Ltd. Bangalore, India The identification of oxidation sites…
Key words
mab, maboxidized, oxidizedoxidation, oxidationntlylq, ntlylqsslr, sslrpeptide, peptidetrypsin, trypsinmonoclonal, monoclonalmass, masstheoretical, theoreticalmsslr, msslrbioconfirm, bioconfirmantibody, antibodyntlylqmsslr, ntlylqmsslrsequence
BIOPHARMA WORKFLOW SOLUTIONS - Drug Development and Quality Control
BIOPHARMA WORKFLOW SOLUTIONS - Drug Development and Quality Control
2017|Agilent Technologies|Brochures and specifications
Drug Development and Quality Control BIOPHARMA WORKFLOW SOLUTIONS HOW AGILENT HELPS RESOLVE COMPLEX ANALYTICAL CHALLENGES + + COMPLEX CHALLENGES The work you do is extraordinarily complicated and labor-intensive; we can help We know you have a lot of samples to…
Key words
glycan, glycanmapping, mappingpeptide, peptidewalkup, walkupprotein, proteinagilent, agilentpump, pumpmab, mabanalysis, analysisantibody, antibodyintact, intactmass, masscapillary, capillaryptms, ptmsregenerate
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike